Navigation Links


Alex's Lemonade Stand Foundation Announces Launch of Country's First Bioinformatics Lab Using 'Big Data' to Cure Childhood Cancer

6/27/2016
PHILADELPHIA , June 27, 2016  Alex's Lemonade Stand Foundation (ALSF), a leading national childhood cancer charity, announced that that it will open a state-of-the-art bioinformatics lab, using 'big data' to advance the pace of childhood cancer research. This announcement comes as Liz Scott , co-executive director of ALSF and Alex's mom, attends the National Ca... [Comments]

The Freedonia Group: World Enzyme Demand to Reach $7.2 Billion

6/27/2016
CLEVELAND , June 27, 2016  Global demand for enzymes is forecast to grow on average 4.6 percent through 2020 to $7.2 billion.  This market includes enzymes used in industrial applications (food and beverages, cleaning products, biofuel production, animal feed, and other markets) and specialty applications (research and biotechnology, diagnostics, and biocatalysts). Fo... [Comments]

Biorem Reports Sale of Securities by Major Shareholders

6/27/2016
GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces that it has been advised by its major shareholders, Clean Technology Fund I, LP and Clean Technology Fund II, LP, United States based venture capital funds which together hold approximately 59% of the common shares of Biorem (on a fully diluted, as converted basis), that they have... [Comments]

The Supreme Court Of The United States Denies Sequenom's Petition Requesting Review Of Decision On '540 Patent

6/27/2016
SAN DIEGO , June 27, 2016  Sequenom, Inc. (NASDAQ: SQNM ), a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced today that the Supreme Court of the United States denied its petition to review decisions by lower Federal courts that the claims of Sequenom's U.S. Patent No. 6,258,540 ("'540... [Comments]

New Study Finds Activin A May be a Novel Mesothelioma Biomarker, According to Surviving Mesothelioma

6/27/2016
Raleigh, NC (PRWEB) June 27, 2016 Cancer experts from Austria, Hungary, Switzerland, and Australia have just published their findings on what they believe could be a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published a summary of the new re... [Comments]

Parallel 6™ Announces the Clinical Reach™ Virtual Patient Encounter Module, CONSULT

6/27/2016
San Diego, CA (PRWEB) June 27, 2016 Parallel 6 , the leading software as a service (SaaS) provider of mClinical solutions for clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication between t... [Comments]

4Sight Medical Solutions created to help the advancement of novel medical technologies

6/27/2016
Raleigh, NC (PRWEB) June 27, 2016 Newly created 4Sight Medical Solutions has a mission to bring innovative medical technologies, services and solutions to the healthcare market. The company's primary focus is on new product introductions, to include the development and implementation of... [Comments]

Amgen Executive Rolf Hoffmann Joins UNC Kenan-Flagler Business School

6/27/2016
Chapel Hill, N.C. (PRWEB) June 27, 2016 Rolf K. Hoffmann, former senior vice president of U.S. commercial operations for Amgen, will join the faculty of the University of North Carolina Kenan-Flagler Business School effective June 27. Hoffmann will serve as adjunct professor of strategy... [Comments]

Liquid Biotech USA, Inc. Announces Collaboration with the University of Pennsylvania and Funding of Sponsored Research Agreement

6/27/2016
PHILADELPHIA , June 27, 2016  Liquid Biotech USA , Inc. ("Liquid") today announced the funding of a Sponsored Research Agreement with The University of Pennsylvania ("PENN") to study circulating tumor cells (CTCs) from cancer patients.  The funding will be used to assess how changes in CTC levels correlate with clinical outcomes in cancer patients undergoing a vari... [Comments]

Ginkgo Bioworks Named as Technology Pioneer by World Economic Forum

6/27/2016
BOSTON , June 27, 2016   Ginkgo Bioworks , a leading organism design company bringing biology to industrial engineering, was today awarded as one of the World Economic Forum's Technology Pioneers, a selection of the world's most innovative companies. Ginkgo Bioworks is engineering biology to manufacture products at scale for the real world in the nutrition, health and... [Comments]

[next]
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
Breaking Biology News(10 mins):
EoProbe Eosinophil Staining Kit, 1 Kit...
... This DuoSet ELISA Development kit contains ... of sandwich ELISAs to measure natural and ... and serum. Each kit contains sufficient ... 96-well plates, provided that the following conditions ...
RABBIT ANTI PORCINE CARBOXYPEPTIDASE B...
Recombinant Ovine (Sheep) Growth Hormone, Ultra Pure...
Biology Products:
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
Breaking Biology Technology: